NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Freenome secures £128m funds for multiomics cancer blood testing platform » bloodplat

Freenome secures £128m funds for multiomics cancer blood testing platform

Image: Freenome has secured £128m funds to advance the development of multiomics cancer blood testing platform. Photo: courtesy of Arek Socha from Pixabay.

NS Medical Devices is using cookies

Image: Freenome has secured £128m funds to advance the development of multiomics cancer blood testing platform. Photo: courtesy of Arek Socha from Pixabay.

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

GE HealthCare, Elekta expand collaboration to boost radiation therapy

Philips secures FDA 510(k) approval for its Zenition 30 mobile C-arm

Hyalex Orthopaedics initiates clinical trials for Hyalex Knee Cartilage System

Expanse ICE gets FDA 510(k) clearance for ICE Aspiration System

Ambu secures FDA nod for new version of aScope Duodeno 2 solution

Recommended Whitepaper